InsiderClue
Insiders · Profile

Moat Ross

CHIEF OPERATING OFFICER at Kiniksa Pharmaceuticals International. Filing since 3 Sep 2024. CIK 0001857177

Company
Date
Role
Action
Shares
Amount
Of holding
KNSA Kiniksa Pharmaceuticals International, plc
9 Apr 2026
CHIEF OPERATING OFFICER
Sold on a plan
1,703
$79.51K
12.4%
KNSA Kiniksa Pharmaceuticals International, plc
6 Apr 2026
CHIEF OPERATING OFFICER
Sold on a plan
2,367
$114.99K
16.4%
KNSA Kiniksa Pharmaceuticals International, plc
4 Sep 2025
CHIEF CORP. & COMM. OFFICER
Sold on a plan
3,523
$124.40K
27.2%
KNSA Kiniksa Pharmaceuticals International, plc
3 Jun 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
27,594
$800.78K
74.6%
KNSA Kiniksa Pharmaceuticals International, plc
5 May 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
6,272
$175.62K
40.0%
KNSA Kiniksa Pharmaceuticals International, plc
2 May 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
3,850
$107.80K
29.0%
KNSA Kiniksa Pharmaceuticals International, plc
1 May 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
23,234
$651.02K
71.2%
KNSA Kiniksa Pharmaceuticals International, plc
29 Apr 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
64,035
$1.61M
87.2%
KNSA Kiniksa Pharmaceuticals International, plc
21 Apr 2025
CHIEF COMMERCIAL OFFICER
Sold on a plan
18,259
$370.48K
66.0%
KNSA Kiniksa Pharmaceuticals International, plc
3 Sep 2024
CHIEF COMMERCIAL OFFICER
Sold on a plan
68,506
$1.79M
75.9%
10 decisions on file.